The Promises of Speeding Up: Changes in Requirements for Animal Studies and Alternatives during COVID-19 Vaccine Approval–A Case Study

SIMPLE SUMMARY: The COVID-19 pandemic led to intensive research into finding new vaccines for human protection. On 21 December 2020, the European Commission granted conditional marketing authorisation for the messenger RNA vaccine ‘Comirnaty’, produced by Pfizer (New York, NY, USA) and BioNTech (Mai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritskes-Hoitinga, Merel, Barella, Yari, Kleinhout-Vliek, Tineke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264994/
https://www.ncbi.nlm.nih.gov/pubmed/35804634
http://dx.doi.org/10.3390/ani12131735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264994/
https://www.ncbi.nlm.nih.gov/pubmed/35804634
http://dx.doi.org/10.3390/ani12131735

Ejemplares similares